Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-036168

Chief Executive Officer sold 8,800 shares at an average $48.56 ($427,288)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-06-05 Sale −3,200 $49.51 $158,432 168,078 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-05 Sale −1,200 $50.27 $60,324 166,878 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-06 Sale −1,900 $46.53 $88,407 164,978 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-06 Sale −1,500 $47.69 $71,535 163,478 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-06 Sale −1,000 $48.59 $48,590 162,478 I
Open-market sales · 8,800 sh · avg $48.56 · $427,288
Loading xslF345X03/doc4.xml…